Last reviewed: May 21, 2026

Last updated: May 21, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Compound semaglutide typically remains stable for 30 days when stored at 2–8°C (refrigerated), though some licensed 503A formulations extend to 90 days. Stability depends on the specific compounding pharmacy's formulation, sterility protocols, and vial construction. Understanding shelf life and storage requirements ensures consistent dosing and treatment continuity.

For patients beginning compounded GLP-1 therapy, knowing medication stability is as important as understanding how your body may respond to it. PlexusDx emphasizes precision wellness: combining practical medication management with genetic insights that may help contextualize your individual treatment pathway with your provider.

Compounded Semaglutide Stability: What Determines How Long It Lasts

Compound semaglutide is manufactured by licensed 503A pharmacies under strict USP <797> standards. Stability is influenced by peptide concentration, preservative formulation, vial material, and headspace sterility. Most compounded preparations maintain potency for 30 days refrigerated; some reach 90 days with extended-stability formulations approved by the compounding pharmacy.

The active semaglutide molecule is sensitive to temperature fluctuations and light exposure. Each licensed pharmacy provides specific expiration guidance based on their compounding process. Patients should always reference their pharmacy's stability data—typically included in patient medication guides—rather than assuming a standard duration.

Storage Requirements and Best Practices for Compounded GLP-1 Therapy

Proper storage directly affects medication efficacy. Compounded semaglutide requires consistent refrigeration at 2–8°C (36–46°F) to maintain potency. Freezing, room-temperature exposure, or direct sunlight degrades the peptide and reduces treatment effectiveness. Most vials include a printed expiration date; exceeding this date risks reduced bioavailability.

Storage Factor Requirement Impact if Not Followed
Temperature 2–8°C refrigerated consistently Peptide degradation, reduced efficacy
Light Exposure Protect from direct sunlight and UV light Chemical breakdown, loss of potency
Vial Integrity Keep sealed, unopened until use Contamination risk, compromised sterility
Freezing Do not freeze compounded semaglutide Crystal formation, irreversible damage
Room Temperature Avoid storage above 8°C or outside fridge Accelerated degradation, shortened shelf life

Comparing 30-Day and Extended-Stability Formulations

Licensed 503A pharmacies may offer both standard 30-day formulations and extended-stability options reaching 90 days. Extended-stability versions typically use enhanced preservatives and specialized vial construction. The choice depends on patient refill patterns, storage capacity, and prescriber preference. Neither formulation is superior—they serve different patient schedules.

Extended-stability formulations allow less frequent pharmacy refills and reduce the risk of medication gaps. However, they require more rigorous storage compliance and may cost slightly more. Your prescriber and pharmacy can recommend the formulation best suited to your treatment plan and lifestyle.

When Biomarkers and Genetics May Influence Your Treatment Continuity

Your genetic predispositions in peptide pathways—revealed by PlexusDx's Precision Peptide Genetic Test—may inform how your provider evaluates your individual response pattern over time. Variants in GLP1R, GIPR, and FTO genes can provide context for how your body processes GLP-1 medications, potentially affecting treatment consistency and adjustment timing.

Understanding your genetic profile may help your provider anticipate whether frequent dose adjustments, alternative formulations, or timing of refills align with your individual pathway. This insight supports a more informed conversation about which compounded semaglutide formulation (30-day or extended-stability) best fits your treatment goals and response pattern.

Safety Considerations and When to Replace Stored Medication

Always check your vial's expiration date before each injection. Expired or improperly stored semaglutide may have reduced potency, risking inadequate therapy or unpredictable effects. If a vial has been left unrefrigerated for more than 2 hours, or if the solution appears cloudy, discolored, or contains particles, do not use it—contact your pharmacy immediately.

Patient adherence to storage guidelines is critical for treatment safety and efficacy. If you travel, use a cooling case or portable medication refrigerator to maintain the 2–8°C range. Inform your healthcare provider of any storage gaps or concerns; they can adjust your refill schedule or formulation choice to match your lifestyle and ensure consistent access to your medication.

How PlexusDx Supports a More Personalized Approach

PlexusDx's Precision Peptide Genetic Test analyzes key variants (GLP1R rs6923761, GIPR rs1800437, FTO rs9939609, MC4R rs17782313) that may help contextualize your individual response predispositions in peptide pathways. This genetic context does not predict exact medication response or duration, but may help provide a framework for understanding how your body processes compounded semaglutide and whether treatment adjustments align with your genetic profile.

The Precision Peptide Genetic Test is available as a $99 add-on to any PlexusDx treatment order or as a standalone $298 test. These predispositions should be interpreted with a qualified healthcare provider—they reveal genetic risk factors and response tendencies, not guarantees. Combined with clinical markers and provider assessment, genetic insights may support more personalized medication selection and dosing strategy.

Understanding both medication stability and your individual genetic context helps create a complete picture of your GLP-1 therapy journey. Share your Precision Peptide Genetic Test results with your provider to discuss whether your compounded semaglutide formulation (30-day or extended-stability), refill schedule, and dose adjustments align with your genetic predispositions and treatment goals. This integrated approach supports more informed, individualized care.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $249/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Related Reading

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves